Home Newsfeeds Evercore ISI Group Maintains Outperform on Align Tech, Raises Price Target to $375

Evercore ISI Group Maintains Outperform on Align Tech, Raises Price Target to $375

Evercore ISI Group analyst Elizabeth Anderson maintains Align Tech (NASDAQ:ALGN) with a Outperform and raises the price target from $230 to $375.

byBenzinga Newsdesk

February 2, 2023

1 minute read

Evercore ISI Group analyst Elizabeth Anderson maintains Align Tech (NASDAQ:ALGN) with a Outperform and raises the price target from $230 to $375.

Nasdaq Rises More Than 1%; Housing Market Index Tumbles To This Much Low Level

By Lisa Levin

July 18, 12:30 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday.

ADN

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday

By Lisa Levin

April 13, 10:38 AM

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.

ALLO

Accenture Invests In Virtonomy To Help Medical Technology Companies Use Digital Twin Technology To Accelerate Time To Market For Medical Devices

By Happy Mohamed

April 12, 9:22 AM

Accenture (NYSE:ACN) has made a strategic investment, through Accenture Ventures, in Virtonomy, a provider of data-driven simulations that use existing patient data and digital twin technology to bring

ACN

Analyst Ratings

4 Analysts Have This to Say About Veeco Instruments

By Benzinga Insights

May 26, 4:00 PM

Over the past 3 months, 4 analysts have published their opinion on Veeco Instruments (NASDAQ:VECO) stock. These analysts…

VECO

Evercore ISI Group Maintains Outperform on Align Tech, Raises Price Target to $375

Related Posts

Nasdaq Rises More Than 1%; Housing Market Index Tumbles To This Much Low Level

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday

Accenture Invests In Virtonomy To Help Medical Technology Companies Use Digital Twin Technology To Accelerate Time To Market For Medical Devices

4 Analysts Have This to Say About Veeco Instruments